Molycorp (NYSE: MCP)‘s stock had its “neutral” rating restated by equities researchers at Goldman Sachs in a report issued on Friday.

Shares of Molycorp (NYSE: MCP) traded up 3.21% during mid-day trading on Friday, hitting $6.182. Molycorp has a one year low of $5.60 and a one year high of $35.79. The stock’s 50-day moving average is currently $6.86. The company’s market cap is $852.9 million.

Molycorp (NYSE: MCP) last released its earnings data on Thursday, March 14th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.15. The company had revenue of $134.30 million for the quarter, compared to the consensus estimate of $165.98 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 1.1% on a year-over-year basis. Analysts expect that Molycorp will post $-0.55 EPS for the current fiscal year.

MCP has been the subject of a number of other recent research reports. Analysts at Piper Jaffray initiated coverage on shares of Molycorp in a research note to investors on Friday. They set a “neutral” rating and a $8.00 price target on the stock. Separately, analysts at Zacks upgraded shares of Molycorp from an “underperform” rating to a “neutral” rating in a research note to investors on Tuesday. They now have a $6.60 price target on the stock. Finally, analysts at JPMorgan Chase upgraded shares of Molycorp from an “underweight” rating to a “neutral” rating in a research note to investors on Thursday, February 7th. They now have a $6.00 price target on the stock, up previously from $5.00.

Two research analysts have rated the stock with a buy rating, and seven have issued a hold rating to the company’s stock. The stock has a consensus rating of “hold” and a consensus target price of $9.75.

Molycorp, Inc. is a rare earth oxide (REO) producer in the Western hemisphere and own most fully developed rare earth project outside of China.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.